Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 6;84(11):2185-2202.e12.
doi: 10.1016/j.molcel.2024.05.001. Epub 2024 May 23.

Retron-Eco1 assembles NAD+-hydrolyzing filaments that provide immunity against bacteriophages

Affiliations
Free article

Retron-Eco1 assembles NAD+-hydrolyzing filaments that provide immunity against bacteriophages

Arturo Carabias et al. Mol Cell. .
Free article

Abstract

Retrons are toxin-antitoxin systems protecting bacteria against bacteriophages via abortive infection. The Retron-Eco1 antitoxin is formed by a reverse transcriptase (RT) and a non-coding RNA (ncRNA)/multi-copy single-stranded DNA (msDNA) hybrid that neutralizes an uncharacterized toxic effector. Yet, the molecular mechanisms underlying phage defense remain unknown. Here, we show that the N-glycosidase effector, which belongs to the STIR superfamily, hydrolyzes NAD+ during infection. Cryoelectron microscopy (cryo-EM) analysis shows that the msDNA stabilizes a filament that cages the effector in a low-activity state in which ADPr, a NAD+ hydrolysis product, is covalently linked to the catalytic E106 residue. Mutations shortening the msDNA induce filament disassembly and the effector's toxicity, underscoring the msDNA role in immunity. Furthermore, we discovered a phage-encoded Retron-Eco1 inhibitor (U56) that binds ADPr, highlighting the intricate interplay between retron systems and phage evolution. Our work outlines the structural basis of Retron-Eco1 defense, uncovering ADPr's pivotal role in immunity.

Keywords: ADP-ribosylation; Ec86; NAD(+); Retron-Eco1; bacteria anti-phage defense; bacterial immune systems; biochemistry; cryoelectron microscopy; enzyme mechanisms; structural biology.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests G.M. is a stockholder and member of the SAB of Ensoma, and M.R.M. is listed as co-inventor of patent application WO2023141602A2, related to the use of engineered retrons for genome editing.

MeSH terms

LinkOut - more resources